Hepatic steatosis associated with exposure to elvitegravir and raltegravir

Ditte Marie Kirkegaard-Klitbo; Magda Teresa Thomsen; Marco Gelpi; Flemming Bendtsen; Susanne Dam Nielsen; Thomas Benfield

doi:10.1093/cid/ciab057

Hepatic steatosis associated with exposure to elvitegravir and raltegravir

Ditte Marie Kirkegaard-Klitbo, Magda Teresa Thomsen, Marco Gelpi, Flemming Bendtsen, Susanne Dam Nielsen, Thomas Benfield

13 Citationer (Scopus)

Abstract

Moderate-to-severe hepatic steatosis in people living with human immunodeficiency virus (HIV) without viral hepatitis or excessive alcohol intake was associated with cumulative exposure to stavudine, elvitegravir, and raltegravir. Prospective trials are required to establish a causal association. Clinical Trials Registration. NCT02382822.

Originalsprog	Engelsk
Artikelnummer	ciab057
Tidsskrift	Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Vol/bind	73
Udgave nummer	3
Sider (fra-til)	e811-e814
Antal sider	4
ISSN	1058-4838
DOI	https://doi.org/10.1093/cid/ciab057
Status	Udgivet - aug. 2021

Adgang til dokumentet

10.1093/cid/ciab057

Andre filer og links

Link to publication in Scopus

Citationsformater

Hepatic steatosis associated with exposure to elvitegravir and raltegravir. / Kirkegaard-Klitbo, Ditte Marie; Thomsen, Magda Teresa; Gelpi, Marco et al.
I: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Bind 73, Nr. 3, ciab057, 08.2021, s. e811-e814.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

@article{37c09967be6e47f2920e0086586e1c4f,

title = "Hepatic steatosis associated with exposure to elvitegravir and raltegravir",

abstract = "Moderate-to-severe hepatic steatosis in people living with human immunodeficiency virus (HIV) without viral hepatitis or excessive alcohol intake was associated with cumulative exposure to stavudine, elvitegravir, and raltegravir. Prospective trials are required to establish a causal association. Clinical Trials Registration. NCT02382822.",

keywords = "HIV Infections/complications, Humans, Prospective Studies, Quinolones/adverse effects, Raltegravir Potassium/adverse effects, NAFLD, ART, HIV",

author = "Kirkegaard-Klitbo, {Ditte Marie} and Thomsen, {Magda Teresa} and Marco Gelpi and Flemming Bendtsen and Nielsen, {Susanne Dam} and Thomas Benfield",

year = "2021",

month = aug,

doi = "10.1093/cid/ciab057",

language = "English",

volume = "73",

pages = "e811--e814",

journal = "Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",

issn = "1058-4838",

publisher = "University of Chicago Press",

number = "3",

}

TY - JOUR

T1 - Hepatic steatosis associated with exposure to elvitegravir and raltegravir

AU - Kirkegaard-Klitbo, Ditte Marie

AU - Thomsen, Magda Teresa

AU - Gelpi, Marco

AU - Bendtsen, Flemming

AU - Nielsen, Susanne Dam

AU - Benfield, Thomas

PY - 2021/8

Y1 - 2021/8

N2 - Moderate-to-severe hepatic steatosis in people living with human immunodeficiency virus (HIV) without viral hepatitis or excessive alcohol intake was associated with cumulative exposure to stavudine, elvitegravir, and raltegravir. Prospective trials are required to establish a causal association. Clinical Trials Registration. NCT02382822.

AB - Moderate-to-severe hepatic steatosis in people living with human immunodeficiency virus (HIV) without viral hepatitis or excessive alcohol intake was associated with cumulative exposure to stavudine, elvitegravir, and raltegravir. Prospective trials are required to establish a causal association. Clinical Trials Registration. NCT02382822.

KW - HIV Infections/complications

KW - Humans

KW - Prospective Studies

KW - Quinolones/adverse effects

KW - Raltegravir Potassium/adverse effects

KW - NAFLD

KW - ART

KW - HIV

UR - http://www.scopus.com/inward/record.url?scp=85113710760&partnerID=8YFLogxK

U2 - 10.1093/cid/ciab057

DO - 10.1093/cid/ciab057

M3 - Journal article

C2 - 33493297

SN - 1058-4838

VL - 73

SP - e811-e814

JO - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

JF - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

IS - 3

M1 - ciab057

ER -

Hepatic steatosis associated with exposure to elvitegravir and raltegravir

Abstract

Adgang til dokumentet

Andre filer og links

Fingeraftryk

Citationsformater